These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31721598)

  • 21. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
    Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
    Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices.
    Grimm SE; Dixon S; Stevens JW
    Value Health; 2016; 19(6):720-726. PubMed ID: 27712696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs.
    Rothery C; Claxton K; Palmer S; Epstein D; Tarricone R; Sculpher M
    Health Econ; 2017 Feb; 26 Suppl 1():109-123. PubMed ID: 28139090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does assessing the value for money of therapeutic medical devices require a flexible approach?
    Iglesias CP
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):21-32. PubMed ID: 25583537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment and non-clinical impact of medical devices.
    Dervaux B; Szwarcensztein K; Josseran A; ; Barna A; Carbonneil C; Chevrie K; Debroucker F; Grumblat A; Grumel O; Massol J; Maugendre P; Méchin H; Orlikowski D; Roussel C; Rumeau-Pichon C; Sales JP; Vicaut E
    Therapie; 2015; 70(1):57-68. PubMed ID: 25747839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical devices early assessment methods: systematic literature review.
    Markiewicz K; van Til JA; IJzerman MJ
    Int J Technol Assess Health Care; 2014 Apr; 30(2):137-46. PubMed ID: 24805836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality assessment of health economic evaluation.
    Chaikledkaew U; Kittrongsiri K
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S113-8. PubMed ID: 24964708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New obstacles in the path of marketing new medical devices.
    Bucci VA; Reiss JB; Hall NC
    J Health Care Technol; 1985; 2(2):81-96. PubMed ID: 10300491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health economics of medical devices: opportunities and challenges.
    Simoens S
    J Med Econ; 2008; 11(4):713-7. PubMed ID: 19450077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Assessment Reviews: is cost-effectiveness analysis helpful or necessary?
    Mistry H; Mason J
    J Health Serv Res Policy; 2018 Oct; 23(4):222-242. PubMed ID: 30309266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental Cost-Effectiveness Ratio and Net Monetary Benefit: Promoting the Application of Value-Based Pricing to Medical Devices-A European Perspective.
    Messori A; Trippoli S
    Ther Innov Regul Sci; 2018 Nov; 52(6):755-756. PubMed ID: 29714590
    [No Abstract]   [Full Text] [Related]  

  • 34. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating option values into the economic evaluation of health care technologies.
    Palmer S; Smith PC
    J Health Econ; 2000 Sep; 19(5):755-66. PubMed ID: 11184803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey.
    Hatz MH; Schreyögg J; Torbica A; Boriani G; Blankart CR
    Health Econ; 2017 Feb; 26 Suppl 1():124-144. PubMed ID: 28139093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten recommendations for assessing the comparative effectiveness of therapeutic medical devices: a targeted review and adaptation.
    Schnell-Inderst P; Hunger T; Conrads-Frank A; Arvandi M; Siebert U
    J Clin Epidemiol; 2018 Feb; 94():97-113. PubMed ID: 29107757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?
    Tarricone R; Torbica A; Ferré F; Drummond M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):707-18. PubMed ID: 25196848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.